BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 30992427)

  • 1. Abnormal development of early auditory processing in 22q11.2 Deletion Syndrome.
    Cantonas LM; Tomescu MI; Biria M; Jan RK; Schneider M; Eliez S; Rihs TA; Michel CM
    Transl Psychiatry; 2019 Apr; 9(1):138. PubMed ID: 30992427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered auditory processing in frontal and left temporal cortex in 22q11.2 deletion syndrome: a group at high genetic risk for schizophrenia.
    Rihs TA; Tomescu MI; Britz J; Rochas V; Custo A; Schneider M; Debbané M; Eliez S; Michel CM
    Psychiatry Res; 2013 May; 212(2):141-9. PubMed ID: 23137800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal Auditory Processing and Underlying Structural Changes in 22q11.2 Deletion Syndrome.
    Cantonas LM; Mancini V; Rihs TA; Rochas V; Schneider M; Eliez S; Michel CM
    Schizophr Bull; 2021 Jan; 47(1):189-196. PubMed ID: 32747926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered auditory processing and effective connectivity in 22q11.2 deletion syndrome.
    Larsen KM; Mørup M; Birknow MR; Fischer E; Hulme O; Vangkilde A; Schmock H; Baaré WFC; Didriksen M; Olsen L; Werge T; Siebner HR; Garrido MI
    Schizophr Res; 2018 Jul; 197():328-336. PubMed ID: 29395612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deviant trajectories of cortical maturation in 22q11.2 deletion syndrome (22q11DS): a cross-sectional and longitudinal study.
    Schaer M; Debbané M; Bach Cuadra M; Ottet MC; Glaser B; Thiran JP; Eliez S
    Schizophr Res; 2009 Dec; 115(2-3):182-90. PubMed ID: 19836927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing auditory processing endophenotypes associated with Schizophrenia in individuals with 22q11.2 deletion syndrome.
    Francisco AA; Foxe JJ; Horsthuis DJ; DeMaio D; Molholm S
    Transl Psychiatry; 2020 Mar; 10(1):85. PubMed ID: 32139692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Auditory change detection in schizophrenia: sources of activity, related neuropsychological function and symptoms in patients with a first episode in adolescence, and patients 14 years after an adolescent illness-onset.
    Oades RD; Wild-Wall N; Juran SA; Sachsse J; Oknina LB; Röpcke B
    BMC Psychiatry; 2006 Feb; 6():7. PubMed ID: 16466573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender-moderated dorsolateral prefrontal reductions in 22q11.2 Deletion Syndrome: implications for risk for schizophrenia.
    Kates WR; Antshel K; Willhite R; Bessette BA; AbdulSabur N; Higgins AM
    Child Neuropsychol; 2005 Feb; 11(1):73-85. PubMed ID: 15823984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visual processing deficits in 22q11.2 Deletion Syndrome.
    Biria M; Tomescu MI; Custo A; Cantonas LM; Song KW; Schneider M; Murray MM; Eliez S; Michel CM; Rihs TA
    Neuroimage Clin; 2018; 17():976-986. PubMed ID: 29527499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant Developmental Patterns of Gamma-Band Response and Long-Range Communication Disruption in Youths With 22q11.2 Deletion Syndrome.
    Mancini V; Rochas V; Seeber M; Roehri N; Rihs TA; Ferat V; Schneider M; Uhlhaas PJ; Eliez S; Michel CM
    Am J Psychiatry; 2022 Mar; 179(3):204-215. PubMed ID: 35236117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developmental trajectories of brain structure in adolescents with 22q11.2 deletion syndrome: a longitudinal study.
    Gothelf D; Penniman L; Gu E; Eliez S; Reiss AL
    Schizophr Res; 2007 Nov; 96(1-3):72-81. PubMed ID: 17804201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [An Adult Case of 22q11.2 Deletion Syndrome with Congenital Abnormalities and Neurodevelopmental Disorders, Which Remained Undiagnosed Until Presentation of Auditory Hallucinations].
    Tamune H; Nishimura F; Koshiyama D; Yamada K; Kondo S; Kano Y; Kasai K
    Seishin Shinkeigaku Zasshi; 2017; 119(1):9-16. PubMed ID: 30629863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COMT Val108/158 Met modifies mismatch negativity and cognitive function in 22q11 deletion syndrome.
    Baker K; Baldeweg T; Sivagnanasundaram S; Scambler P; Skuse D
    Biol Psychiatry; 2005 Jul; 58(1):23-31. PubMed ID: 15935994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 22q11.2 Deletion Syndrome Is Associated With Impaired Auditory Steady-State Gamma Response.
    Larsen KM; Pellegrino G; Birknow MR; Kjær TN; Baaré WFC; Didriksen M; Olsen L; Werge T; Mørup M; Siebner HR
    Schizophr Bull; 2018 Feb; 44(2):388-397. PubMed ID: 28521049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Schizophrenia-like neurophysiological abnormalities in 22q11.2 deletion syndrome and their association to COMT and PRODH genotypes.
    Zarchi O; Carmel M; Avni C; Attias J; Frisch A; Michaelovsky E; Patya M; Green T; Weinberger R; Weizman A; Gothelf D
    J Psychiatr Res; 2013 Nov; 47(11):1623-9. PubMed ID: 23910792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration of functional brain architecture in 22q11.2 deletion syndrome - Insights into susceptibility for psychosis.
    Larsen KM; Dzafic I; Siebner HR; Garrido MI
    Neuroimage; 2019 Apr; 190():154-171. PubMed ID: 30195053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Premorbid adjustment and schizophrenia in individuals with 22q11.2 deletion syndrome.
    Yuen T; Chow EW; Silversides CK; Bassett AS
    Schizophr Res; 2013 Dec; 151(1-3):221-5. PubMed ID: 24262682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Auditory mismatch negativity in schizophrenia: topographic evaluation with a high-density recording montage.
    Hirayasu Y; Potts GF; O'Donnell BF; Kwon JS; Arakaki H; Akdag SJ; Levitt JJ; Shenton ME; McCarley RW
    Am J Psychiatry; 1998 Sep; 155(9):1281-4. PubMed ID: 9734556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Auditory mismatch negativity and P3a in response to duration and frequency changes in the early stages of psychosis.
    Nagai T; Tada M; Kirihara K; Yahata N; Hashimoto R; Araki T; Kasai K
    Schizophr Res; 2013 Nov; 150(2-3):547-54. PubMed ID: 24012461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duration and frequency mismatch negativity shows no progressive reduction in early stages of psychosis.
    Koshiyama D; Kirihara K; Tada M; Nagai T; Koike S; Suga M; Araki T; Kasai K
    Schizophr Res; 2017 Dec; 190():32-38. PubMed ID: 28314681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.